Healthcare Business

Good heart health

Thursday’s Top Biopharma Movers

Not that many biotech and pharma companies were on the move Thursday, just one day before the inauguration. However, a few of the smaller caps made splash, while broad markets ...
Read Full Story »
automatic inspection machine

Baird Has 4 Red-Hot Biotechs to Buy for 2017 With Huge Upside Potential

Needless to say, the past two years have been rough on biotech. So rough in fact, that a basket of the largest capitalization stocks now trade with a price-to-earnings growth ...
Read Full Story »
graph

How Erectile Dysfunction in Mexico Just Made One Micro-Cap Stock More Than Double

The biotechs and emerging pharma have been under pressure from politicians attacking drug prices. That doesn't mean that there are not some big winners out there. Sometimes the biggest winners are ...
Read Full Story »
Jon's friends

Wednesday’s Top Biopharma Winners

The third week of the New Year is halfway over, and a few biopharma companies made massive runs on the day. The health care sector was in trouble over the ...
Read Full Story »
bigger fish

What Eli Lilly Gets With CoLucid Acquisition

Eli Lilly and Co. (NYSE: LLY) has announced it has reached an agreement to acquire CoLucid Pharmaceuticals Inc. (NASDAQ: CLCD) in an all-cash transaction for $46.50 per share, or about ...
Read Full Story »
Female patient on gurney

Tuesday’s Top Biopharma Movers

Some biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off. ...
Read Full Story »
Doctor, Health (pulse) copy

UnitedHealth Takes Aim at New 52-Week High After Solid Earnings

UnitedHealth Group Inc. (NYSE: UNH) reported fourth-quarter and full-year 2016 results before markets opened Tuesday morning. The health insurance and benefits management firm reported adjusted diluted quarterly earnings per share ...
Read Full Story »
white pills

Merck Is Best Performing DJIA Stock So Far in 2017

The Dow Jones Industrial Average came within a hair of reaching the 20,000 mark on January 6 but has since dropped back to close Friday at 19,885.73. Since the November ...
Read Full Story »
Good heart health

Thursday’s Biggest Biopharma Winners

The health care sector was in trouble over the past year, coming under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could ...
Read Full Story »
Medicine pills

Why 3 Analysts Upgraded Merck Simultaneously

It may seem hard to believe that a Big Pharma drug stock might be a favorite for the year ahead when the attacks against drug pricing and competition do not ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
research

Biotech Short Sellers Run for Cover

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
100 dollar bills

Wednesday’s Top Biopharma Movers

Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive ...
Read Full Story »
Doctor, Health (pulse) copy

Tuesday’s Top Biopharma Movers

Considering the new Trump administration, there is an increasingly positive sentiment in the healthcare sector. In the past year, the health care sector was under fire from congressional hearings and ...
Read Full Story »
Valeant Pharmaceuticals

Why Valeant Is Making a Run

Valeant Pharmaceuticals International Inc. (NYSE: VRX) made waves early on Tuesday after the company offered a plethora of announcements. First the company gave an update on its late-stage psoriasis trial. ...
Read Full Story »